Smoking Cessation for Hospital Employees With Low Education. (RESPEKT)
Smoking Cessation for Hospital Employees With Low Education in the Capital Region of Denmark. The RESPEKT Study.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The target group of this trial is smokers with low education working in hospitals in the Capital Region of Denmark.
The aim is to develop a new tailored smoking cessation program for and together with smokers with low education. We selected following seven positions/occupations as proxy for low socioeconomic status: cleaner, porter, kitchen staff, social and health care assistant, service assistant, technical staff and medial secretary.
In first step the investigators perform focus group interviews with the target group to identify wishes and barriers. In next step the investigators design the new tailored smoking cessation program together with smokers with low education.
Then the investigators test the effect of the smoking cessation program in a randomised controlled trial. All hospitals in the Capital Region of Denmark except one are included (the last hospital is situated on a remote island). Half of the hospitals are randomised to be intervention group and the other half is control group. Recruitment will be by written invitations, posters and primarily by peer-recruitment (smokers with low education who are ambassadors for the project at the work places). Posters and written invitations show photos of the ambassadors in the target group and their statements; why they have decided to quit smoking.
The group-based smoking cessation intervention is designed with guidance from the anchor persons. There is no moralizing or disease-focusing, few written materials and a lot of drawings and humor. The intervention will be in small groups (4-6 persons), with six sessions (á 1½-2 hours) taking place at the workplace during working time. All counsellors are ex-smokers. Stress-management is included at each session. We offer free nicotine products or varenicline by choice, for up to 12 weeks. Nicotine replacement therapy is always based on the patch and combined with inhaler or mouth spray p.n. Nicotine gum is not offered.
The investigators measure validated abstinence rates at each session and 6 months after last session.
Main end-point is smoking rates after 12 months in intervention hospitals compared with smoking rates in control hospitals.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Glostrup, Danimarca, 2600
- Research Center for Prevention and Health
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria: employee with low education working in an intervention hospital in the Capital Region of Denmark.
We selected following seven positions/occupations as proxy for low socioeconomic status: cleaner, porter, kitchen staff, social and health care assistant, service assistant, technical staff and medial secretary.
-
Exclusion Criteria:
- does not speak Danish
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Targeted smoking cessation
Smoking cessation program tailored in cooperation with the target group; smokers with low education. Peer-based anti-relapse strategy. Recruitment strategy: peer-driven, written invitations and posters. |
Smoking cessation program developed in cooperation with and aimed at smokers with low education.
Altri nomi:
|
|
Nessun intervento: Control
No smoking cessation program.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Smoking rate in hospitals randomised to intervention or control group
Lasso di tempo: 12 months
|
Self-reported point abstinence
|
12 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Smoking cessation rate in persons participating in the group-based intervention
Lasso di tempo: 6 months
|
Self-reported point abstinence + carbonmonoxide validated abstinence
|
6 months
|
|
Smoking cessation rate in persons participating in the intervention
Lasso di tempo: 6 weeks after fixed quit date
|
Carbonmonoxide validated abstinence
|
6 weeks after fixed quit date
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Charlotta Pisinger, MD PhD MPH, Research Center for Prevention and Health
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- F-51061
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Smettere di fumare
-
Poitiers University HospitalNon ancora reclutamentoTerapia sostitutiva della nicotina | Professionisti sanitari | Desiderio di Tabacco | Tabacco CessationFrancia
Prove cliniche su Targeted smoking cessation
-
Second Affiliated Hospital, School of Medicine,...Non ancora reclutamentoTerapia cellulare | Cardiomiopatia ischemica
-
Endourage, LLCCompletatoLungo COVID | Lungo Covid19 | Post-acuto COVID-19 | Lungo raggio COVID | COVID-19 a lungo raggio | Sindrome post-acuta da COVID-19Stati Uniti
-
University of California, San FranciscoCompletato
-
Endourage, LLCCompletato
-
University Health Network, TorontoReclutamento
-
Baystate Medical CenterTerminatoSindrome da distress respiratorio, neonato | Prematurità | BPD - Displasia broncopolmonareStati Uniti
-
Mayo ClinicNational Cancer Institute (NCI)ReclutamentoMieloma multiplo refrattario | Mieloma multiplo ricorrenteStati Uniti